ACS to hold teleconference on research and development in the pharmaceutical industry

WASHINGTON, May 12, 2009 — News media covering medicine, health, chemistry and related topics are invited to join an American Chemical Society (ACS) Careers Industry Forum teleconference on innovation and research in today’s pharmaceutical industry.


Michael Bernstein


Scheduled for 2 – 3 p.m. Eastern Time on May 14, the teleconference will feature John L. LaMattina, Ph.D., former Senior Vice President of Pfizer Inc. and President of Pfizer Global Research and Development (R&D). The topic: “From a Chemistry Set as a Ten-Year-Old to Running R&D for a major Pharmaceutical Company." At Pfizer, LaMattina oversaw the drug discovery and development efforts of more than 12,000 colleagues in the United States, Europe and Asia. His research at Pfizer involved seeking new therapeutic agents for treatment of digestive disorders and asthma.

LaMattina, who retired in December 2007, is the author of “Drug Truths: Dispelling the Myths about Pharma R&D” as well as numerous scientific publications and U.S. patents.

The series of teleconferences is scheduled monthly (with the exception of December) through 2009, according to Liane Gould, manager of career services for ACS. There will be a 30-minute discussion with LaMattina followed by a 25-minute Q & A session.

News media can tune into the conference without charge, but must register in advance at the ACS Careers website, which also provides information about future forums.